InvestSMART

Emyria Limited (ASX:EMD)

ALERT: Price-sensitive ASX Announcement for EMD
Current share price for EMD : $0.040 0.001 (2.56%)+
Announcement
Release
18 May 2026 9:10AM
Price at Release
$0.039
Full Release
download
Summary
Emyria Limited, a leader in innovative mental health treatments, has announced the activation of its first Empax clinic in Victoria, which marks the expansion of its operations across three states in Australia. The clinic, located within Avive’s Mornington Peninsula Private Hospital, commenced patient treatments, meeting its targeted launch date in the second quarter of the calendar year 2026. Emyria has recruited over 30 therapists and confirmed its first TGA-approved Authorised Prescriber, with additional applications in progress. The clinic offers dual reimbursement pathways, combining private health insurance and government funding. This strategic move is expected to support the early utilization of the clinic and facilitate the growth of reimbursable, evidence-based complex mental health treatments.
Key Points
  • First Victorian Empax clinic activated.
  • Clinic operational by Q2 CY2026.
  • Located in Avive's Mornington Peninsula Private Hospital.
  • Over 30 therapists recruited and trained.
  • First TGA Approved Authorised Prescriber confirmed.
  • Dual reimbursement pathways available.
  • Revenue activation supported by private and government funding.
  • Infrastructure and workforce established for early utilization.
  • Supported by strong clinical evidence.
  • Board approved the release.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.